Literature DB >> 1715335

Modulation of granuloma formation in vitro by endogenous mediators.

I Y Sato1, K Kobayashi, N Yamagata, Y Shikama, T Kasama, K Kasahara, T Takahashi.   

Abstract

We have reported previously that in vitro granulomas are inducible by culturing murine spleen cells in the presence of artificial microparticles, dextran beads, and that macrophages and macrophage-derived cytokines (monokines) including interleukin 1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) play a critical role in the initiation of bead-induced granulomas in vitro. To investigate regulatory mechanisms of granuloma formation, we examined the modulatory effects of various mediators such as IL-1, TNF-alpha, interferon-gamma (IFN-gamma), IL-4, IL-6, transforming growth factor-beta (TGF-beta), dexamethasone and prostaglandin E2 (PGE2) on the development of lesions, because these mediators are known to play a pivotal role in inflammatory responses. The lesions were suppressed by the addition of dexamethasone, PGE2 or certain T cell-derived lymphokines such as IL-4 and IFN-gamma. These results suggest that suppressive signals are different from granulomatogenic cytokines including IL-1 and TNF-alpha and that granulomas are regulated by multi-factor dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715335     DOI: 10.1016/0162-3109(91)90010-v

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  3 in total

1.  Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat.

Authors:  C M Flory; M L Jones; B F Miller; J S Warren
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

2.  Isolation and characterization of granuloma initiation factor.

Authors:  M A Fung; N Sato; T Tida; K Fukuyama; W L Epstein
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

3.  The C-Type Lectin Mincle: Clues for a Role in Crohn's Disease Adjuvant Reaction.

Authors:  Anje A Te Velde
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.